Medtronic plc recently announced it added AI capabilities to its Reveal Linq insertable cardiac monitor (ICM) to reduce false alerts.
The AccuRythm AI algorithms went live this week in all Reveal Linq devices in the US, Australia and New Zealand...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?